Skip to main content
. 2021 Dec 15;2021(12):CD008012. doi: 10.1002/14651858.CD008012.pub4

Comparison 3. Pharmacological intervention versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
3.1 Depression symptoms ‐ short term 8 750 Std. Mean Difference (IV, Random, 95% CI) ‐0.83 [‐1.33, ‐0.32]
3.2 Depression symptoms change score ‐ short term 3 482 Std. Mean Difference (IV, Random, 95% CI) ‐0.18 [‐0.36, ‐0.00]
3.3 Depression remission ‐ short term 4 646 Odds Ratio (IV, Random, 95% CI) 2.06 [1.47, 2.89]
3.4 Depression response ‐ short term 5 891 Odds Ratio (IV, Random, 95% CI) 2.73 [1.65, 4.54]
3.5 All‐cause mortality ‐ short term 2 437 Odds Ratio (IV, Random, 95% CI) 0.38 [0.10, 1.47]
3.6 All‐cause mortality ‐ long term 2 661 Odds Ratio (IV, Random, 95% CI) 0.89 [0.64, 1.25]
3.7 Cardiovascular mortality ‐ long term 1   Odds Ratio (IV, Random, 95% CI) Totals not selected
3.8 Myocardial infarction ‐ short term 3 728 Odds Ratio (IV, Random, 95% CI) 0.74 [0.26, 2.09]
3.9 Myocardial infarction ‐ long term 1   Odds Ratio (IV, Random, 95% CI) Subtotals only
3.10 Angina ‐ short term 4 819 Odds Ratio (IV, Random, 95% CI) 0.75 [0.44, 1.28]
3.11 Heart failure ‐ short term 3 602 Odds Ratio (IV, Random, 95% CI) 0.93 [0.33, 2.62]
3.12 Arrhythmia ‐ short term 2 87 Odds Ratio (IV, Random, 95% CI) 0.46 [0.01, 17.06]
3.13 Stroke ‐ short term 2 586 Odds Ratio (IV, Random, 95% CI) 0.99 [0.20, 4.96]
3.14 Coronary revascularisation procedure ‐ long term 1 300 Odds Ratio (IV, Random, 95% CI) 0.59 [0.32, 1.10]
3.15 Healthcare costs ‐ short term 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3.16 Hospitalisations ‐ short term 3 514 Odds Ratio (M‐H, Random, 95% CI) 0.58 [0.39, 0.85]
3.17 Emergency department visits ‐ short term 1   Odds Ratio (M‐H, Random, 95% CI) Subtotals only
3.18 Quality of life Q‐LES‐Q ‐ short term 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3.19 Quality of life WHOQOL‐BREF Physical ‐ short term 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3.20 Quality of life WHOQOL‐BREF Psychological ‐ short term 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3.21 Quality of life WHOQOL‐BREF Social relationships ‐ short term 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3.22 Quality of life WHOQOL‐BREF Environmental ‐ short term 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3.23 Quality of life WHOQOL‐BREF Physical ‐ medium term 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3.24 Quality of life WHOQOL‐BREF Psychological ‐ medium term 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3.25 Quality of life WHOQOL‐BREF Social Relationships ‐ medium term 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3.26 Quality of life WHOQOL‐BREF Environmental ‐ medium term 1   Mean Difference (IV, Random, 95% CI) Totals not selected
3.27 Systolic BP ‐ short term 3 675 Mean Difference (IV, Random, 95% CI) ‐0.24 [‐3.52, 3.05]
3.28 Diastolic BP ‐ short term 3 675 Mean Difference (IV, Random, 95% CI) 0.60 [‐1.55, 2.74]
3.29 Heart rate ‐ short term 4 662 Mean Difference (IV, Random, 95% CI) ‐0.80 [‐2.40, 0.79]
3.30 Platelet biomarker βTG ‐ short term 3 141 Std. Mean Difference (IV, Random, 95% CI) ‐0.54 [‐0.99, ‐0.09]
3.31 Platelet biomarker PF4 ‐ short term 3 144 Std. Mean Difference (IV, Random, 95% CI) ‐0.14 [‐0.48, 0.19]
3.32 Platelet biomarker P‐selectin ‐ short term 2 121 Std. Mean Difference (IV, Random, 95% CI) ‐0.31 [‐1.12, 0.50]
3.33 Platelet biomarker PECAM‐1 ‐ short term 1   Mean Difference (IV, Random, 95% CI) Subtotals only
3.34 Platelet biomarker TxB 2 ‐ short term 1   Mean Difference (IV, Random, 95% CI) Subtotals only
3.35 ECG PR interval ‐ short term 3 635 Mean Difference (IV, Random, 95% CI) ‐4.35 [‐8.40, ‐0.31]
3.36 ECG QRS interval ‐ short term 3 635 Mean Difference (IV, Random, 95% CI) 2.37 [‐0.41, 5.15]
3.37 ECG QT interval ‐ short term 1   Mean Difference (IV, Random, 95% CI) Subtotals only
3.38 ECG QTc interval ‐ short term 3 635 Mean Difference (IV, Random, 95% CI) 2.76 [‐1.96, 7.47]
3.39 Non‐cardiac adverse events and side effects ‐ short term 8 1193 Odds Ratio (M‐H, Random, 95% CI) 1.44 [1.07, 1.92]